• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EGFR overexpression in squamous cell carcinoma of the penis.

作者信息

Lavens N, Gupta R, Wood L A

机构信息

Urology Department, QEII Health Sciences Centre, Halifax, NS.

出版信息

Curr Oncol. 2010 Feb;17(1):4-6. doi: 10.3747/co.v17i1.471.

DOI:10.3747/co.v17i1.471
PMID:20179797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2826775/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb86/2826775/6d12f4d6af49/conc17-1-4f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb86/2826775/6d12f4d6af49/conc17-1-4f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb86/2826775/6d12f4d6af49/conc17-1-4f1.jpg

相似文献

1
EGFR overexpression in squamous cell carcinoma of the penis.阴茎鳞状细胞癌中表皮生长因子受体（EGFR）的过表达
Curr Oncol. 2010 Feb;17(1):4-6. doi: 10.3747/co.v17i1.471.
2
Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.阴茎癌中表皮生长因子受体、切除修复交叉互补组1蛋白和胸苷酸合成酶的表达
Clin Genitourin Cancer. 2016 Oct;14(5):450-456.e1. doi: 10.1016/j.clgc.2016.01.013. Epub 2016 Feb 6.
3
Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis.表皮生长因子受体作为阴茎鳞状细胞癌不良生存预测指标
Hum Pathol. 2017 Mar;61:97-104. doi: 10.1016/j.humpath.2016.07.041. Epub 2016 Nov 15.
4
Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.微小RNA-146a的下调与阴茎鳞状细胞癌中的高危型人乳头瘤病毒感染及表皮生长因子受体过表达相关。
Hum Pathol. 2017 Mar;61:33-40. doi: 10.1016/j.humpath.2016.10.019. Epub 2016 Nov 4.
5
Pseudoangiosarcomatous squamous cell carcinoma: first case report on penis.假性血管肉瘤样鳞状细胞癌：阴茎首例病例报告
Transl Androl Urol. 2021 Apr;10(4):1803-1806. doi: 10.21037/tau-20-1234.
6
Etiology of squamous cell carcinoma of the penis.阴茎鳞状细胞癌的病因。
Scand J Urol Nephrol Suppl. 2000(205):189-93. doi: 10.1080/00365590050509913.
7
Metastasis to the penis in a patient with squamous cell carcinoma of the lung with a review of reported cases.一名肺癌鳞状细胞癌患者发生阴茎转移并对报告病例进行综述
Lung Cancer. 2001 Oct;34(1):149-52. doi: 10.1016/s0169-5002(01)00226-4.
8
Long-term outcome of excisional organ sparing surgery for carcinoma of the penis.阴茎癌根治性切除术的长期疗效。
J Urol. 2011 Oct;186(4):1303-7. doi: 10.1016/j.juro.2011.05.084.
9
Secondary NK/T cell lymphoma after radiotherapy for non-HPV-related squamous cell carcinoma of the penis: an early warning event and literature review.阴茎非HPV相关鳞状细胞癌放疗后发生的继发性NK/T细胞淋巴瘤：一个预警事件及文献综述
Int J Clin Exp Pathol. 2020 Aug 1;13(8):2173-2180. eCollection 2020.
10
Pathological Fracture of the Femur by Metastatic Carcinoma Penis-a Rare Presentation.阴茎转移性癌导致股骨病理性骨折——一种罕见的表现。
Indian J Surg. 2016 Apr;78(2):149-50. doi: 10.1007/s12262-015-1379-4. Epub 2015 Oct 30.

引用本文的文献

1
New Therapeutic Horizons for Advanced or Metastatic Penile Cancer.晚期或转移性阴茎癌的新治疗前景。
Urol Clin North Am. 2024 Aug;51(3):367-376. doi: 10.1016/j.ucl.2024.03.005. Epub 2024 May 18.
2
Potential Receptors for Targeted Imaging of Lymph Node Metastases in Penile Cancer.阴茎癌淋巴结转移靶向成像的潜在受体
Diagnostics (Basel). 2020 Sep 15;10(9):694. doi: 10.3390/diagnostics10090694.
3
Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.超越晚期疾病的化疗——表皮生长因子受体（EGFR）和程序性死亡受体1（PD-1）抑制剂的作用

本文引用的文献

1
Cetuximab for the treatment of colorectal cancer.西妥昔单抗用于治疗结直肠癌。
N Engl J Med. 2007 Nov 15;357(20):2040-8. doi: 10.1056/NEJMoa071834.
2
Incidence trends in primary malignant penile cancer.原发性阴茎恶性肿瘤的发病率趋势
Urol Oncol. 2007 Sep-Oct;25(5):361-7. doi: 10.1016/j.urolonc.2006.08.029.
3
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
Transl Androl Urol. 2017 Oct;6(5):848-854. doi: 10.21037/tau.2017.03.92.
4
Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.阴茎癌中表皮生长因子受体、切除修复交叉互补组1蛋白和胸苷酸合成酶的表达
Clin Genitourin Cancer. 2016 Oct;14(5):450-456.e1. doi: 10.1016/j.clgc.2016.01.013. Epub 2016 Feb 6.
5
Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks.阴囊鳞状细胞癌：超越烟囱管帽的审视
World J Clin Cases. 2014 Nov 16;2(11):654-60. doi: 10.12998/wjcc.v2.i11.654.
6
Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.表皮生长因子受体靶向治疗局部晚期或转移性阴茎鳞状细胞癌。
BJU Int. 2014 Jun;113(6):871-7. doi: 10.1111/bju.12450.
7
Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab.耐药性转移性阴茎癌及对含紫杉醇和表皮生长因子受体单克隆抗体尼妥珠单抗的生物化疗的反应
Indian J Med Paediatr Oncol. 2013 Jan;34(1):24-7. doi: 10.4103/0971-5851.113411.
8
Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study.细胞溶质磷酸化表皮生长因子受体可预测早期阴茎癌患者的复发：一项回顾性研究。
J Transl Med. 2013 Jul 2;11:161. doi: 10.1186/1479-5876-11-161.
9
Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma.阴茎鳞状细胞癌中的表皮生长因子受体（EGFR）-RAS 信号通路。
PLoS One. 2013 Apr 24;8(4):e62175. doi: 10.1371/journal.pone.0062175. Print 2013.
10
Penile cancer: current therapy and future directions.阴茎癌：当前的治疗方法和未来方向。
Ann Oncol. 2013 May;24(5):1179-89. doi: 10.1093/annonc/mds635. Epub 2013 Jan 4.
一项开放标签、非对照、多中心II期研究，旨在评估西妥昔单抗单药治疗对铂类治疗无效的复发和/或转移性头颈部鳞状细胞癌患者的疗效和毒性。
J Clin Oncol. 2007 Jun 1;25(16):2171-7. doi: 10.1200/JCO.2006.06.7447.
4
Erlotinib in previously treated non-small-cell lung cancer.厄洛替尼用于既往接受过治疗的非小细胞肺癌。
N Engl J Med. 2005 Jul 14;353(2):123-32. doi: 10.1056/NEJMoa050753.
5
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.厄洛替尼（一种口服表皮生长因子受体酪氨酸激酶抑制剂）用于复发性或转移性头颈部鳞状细胞癌患者的多中心II期研究。
J Clin Oncol. 2004 Jan 1;22(1):77-85. doi: 10.1200/JCO.2004.06.075.
6
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.ZD1839用于复发性或转移性头颈部鳞状细胞癌的II期试验。
J Clin Oncol. 2003 May 15;21(10):1980-7. doi: 10.1200/JCO.2003.10.051.
7
The EGF receptor family as targets for cancer therapy.作为癌症治疗靶点的表皮生长因子受体家族
Oncogene. 2000 Dec 27;19(56):6550-65. doi: 10.1038/sj.onc.1204082.
8
EGF receptor.表皮生长因子受体
Int J Biochem Cell Biol. 1999 Jun;31(6):637-43. doi: 10.1016/s1357-2725(99)00015-1.
9
Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study.顺铂、甲氨蝶呤和博来霉素治疗阴茎癌：西南肿瘤学组的一项研究
J Urol. 1999 Jun;161(6):1823-5.
10
Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.转移性或局部晚期泌尿生殖系统鳞状细胞癌的联合化疗：甲氨蝶呤、顺铂和博来霉素的II期研究
J Urol. 1998 Nov;160(5):1770-4.